nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: Nonrandomized comparison with conventional fractionation
|
Jereczek-Fossa, Barbara Alicja |
|
2011 |
29 |
5 |
p. 523-532 10 p. |
artikel |
2 |
Application of metabolomics to prostate cancer
|
Trock, Bruce J. |
|
2011 |
29 |
5 |
p. 572-581 10 p. |
artikel |
3 |
Choosing the right urinary diversion: Patient's choice or surgeon's inclination?
|
Skinner, Eila C. |
|
2011 |
29 |
5 |
p. 473-475 3 p. |
artikel |
4 |
Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: Results from a single institution series
|
Tilki, Derya |
|
2011 |
29 |
5 |
p. 508-514 7 p. |
artikel |
5 |
Commentary on “Contemporary clinical epidemiology of renal cell carcinoma: Insight from a population based case-control study.” Miller DC, Ruterbusch J, Colt JS, Davis FG, Linehan WM, Chow WH, Schwartz K, Department of Urology, University of Michigan and Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI
|
Boorjian, Stephen |
|
2011 |
29 |
5 |
p. 584- 1 p. |
artikel |
6 |
Commentary on “Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery.” Silberstein JL, Millard F, Mehrazin R, Kopp R, Bazzi W, DiBlasio CJ, Patterson AL, Downs TM, Yunus F, Kane CJ, Derweesh IH, Division of Urology, Department of Surgery, University of California San Diego, School of Medicine San Diego, CA
|
Boorjian, Stephen |
|
2011 |
29 |
5 |
p. 586-587 2 p. |
artikel |
7 |
Commentary on “Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: Comparison with nephrectomy assessment.” Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E, Tannir NM, Wood CG, Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, TX
|
Boorjian, Stephen |
|
2011 |
29 |
5 |
p. 584-585 2 p. |
artikel |
8 |
Commentary on “The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy.” Choueiri TK, Xie W, Kollmannsberger C, North S, Knox JJ, Lampard JG, McDermott DF, Rini BI, Heng DY, Kidney Cancer Center, Dana Farber Cancer Institute, Boston, MA
|
Boorjian, Stephen |
|
2011 |
29 |
5 |
p. 583-584 2 p. |
artikel |
9 |
Commentary on “Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma.” Choueiri TK, Lim ZD, Hirsch, MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM, Dana-Farber Cancer Institute, Boston, MA
|
Boorjian, Stephen |
|
2011 |
29 |
5 |
p. 585-586 2 p. |
artikel |
10 |
Contents
|
|
|
2011 |
29 |
5 |
p. v-vii nvt p. |
artikel |
11 |
Diffuse lymphangiomatosis with genital involvement—evaluation with magnetic resonance lymphangiography
|
Lohrmann, Christian |
|
2011 |
29 |
5 |
p. 515-522 8 p. |
artikel |
12 |
Editorial Board
|
|
|
2011 |
29 |
5 |
p. iii- 1 p. |
artikel |
13 |
Evolution of renal function in patients treated with antiangiogenics after nephrectomy for renal cell carcinoma
|
Launay-Vacher, Vincent |
|
2011 |
29 |
5 |
p. 492-494 3 p. |
artikel |
14 |
Expression of cell cycle-associated proteins in non-muscle-invasive bladder cancer: Correlation with intravesical recurrence following transurethral resection
|
Behnsawy, Hosny M. |
|
2011 |
29 |
5 |
p. 495-501 7 p. |
artikel |
15 |
Expression of glutathione-S-transferases isoenzymes and p53 in exfoliated human bladder cancer cells
|
Oğuztüzün, Serpil |
|
2011 |
29 |
5 |
p. 538-544 7 p. |
artikel |
16 |
Immunohistochemistry for the differential diagnosis of renal tumors with oncocytic features
|
Fernández-Aceñero, M. Jesus |
|
2011 |
29 |
5 |
p. 545-549 5 p. |
artikel |
17 |
Influence of obesity on the incidence and treatment of genitourinary malignancies
|
Stewart, Suzanne Biehn |
|
2011 |
29 |
5 |
p. 476-486 11 p. |
artikel |
18 |
Information for Authors
|
|
|
2011 |
29 |
5 |
p. 588- 1 p. |
artikel |
19 |
Magnetic resonance spectroscopy: A promising tool for the diagnostics of human prostate cancer?
|
Kurth, Johannes |
|
2011 |
29 |
5 |
p. 562-571 10 p. |
artikel |
20 |
Masthead
|
|
|
2011 |
29 |
5 |
p. iv- 1 p. |
artikel |
21 |
Metabolomics and bladder cancer
|
Hyndman, Matthew E. |
|
2011 |
29 |
5 |
p. 558-561 4 p. |
artikel |
22 |
Metabolomics and urologic oncology
|
Bivalacqua, Trinity J. |
|
2011 |
29 |
5 |
p. 550- 1 p. |
artikel |
23 |
miRNA analysis of prostate cancer by quantitative real time PCR: Comparison between formalin-fixed paraffin embedded and fresh-frozen tissue
|
Leite, Katia R.M. |
|
2011 |
29 |
5 |
p. 533-537 5 p. |
artikel |
24 |
Significance of nuclear grade and tumor size in Korean patients with chromophobe renal cell carcinoma: A comparison with conventional renal cell carcinoma
|
Ku, Ja Hyeon |
|
2011 |
29 |
5 |
p. 487-491 5 p. |
artikel |
25 |
Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma
|
Baytekin, Firat |
|
2011 |
29 |
5 |
p. 502-507 6 p. |
artikel |
26 |
Survey Section Editorial Board
|
|
|
2011 |
29 |
5 |
p. 582- 1 p. |
artikel |
27 |
Urine metabolomics for kidney cancer detection and biomarker discovery
|
Ganti, Sheila |
|
2011 |
29 |
5 |
p. 551-557 7 p. |
artikel |